Semaglutide’s patent expired on Friday, and several top Indian drugmakers will launch cheaper generics immediately, with intense competition expected.
​Semaglutide’s patent expired on Friday, and several top Indian drugmakers will launch cheaper generics immediately, with intense competition expected.  by Soban News (international And National News)
